Author:
Apostolidis Leonidas,Schwarz Daniel,Xia Annie,Weiler Markus,Heckel Andreas,Godel Tim,Heiland Sabine,Schlemmer Heinz-Peter,Jäger Dirk,Bendszus Martin,Bäumer Philipp
Publisher
Public Library of Science (PLoS)
Reference38 articles.
1. Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51;Cancer treatment reviews,2004
2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;A de Gramont;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2000
3. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie;SE Al-Batran;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2008
4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;T Conroy;N Engl J Med,2011
5. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis;V Golfinopoulos;The Lancet Oncology,2007
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献